531681 AMERISE

Amerise Biosciences Share Price

₹0.96 +0.04 (4.35%)

23 Nov, 2024 21:36

SIP TrendupStart SIP in AMERISE

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 6.67%
  • Over 3 Month + 33.33%
  • Over 6 Month + 60%
  • Over 1 Year + 65.52%
SIP Lightning

Smart Investing Starts Here Start SIP with Amerise Biosciences for Steady Growth!

Invest Now

Amerise Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Amerise Biosciences Financials

Amerise Biosciences Technicals

EMA & SMA

Current Price
₹0.96
+ 0.04 (4.35%)
pointer
  • stock-down_img
  • Bullish Moving Average 8
  • stock-up_img
  • Bearish Moving Average 8
  • 20 Day
  • ₹0.97
  • 50 Day
  • ₹0.91
  • 100 Day
  • ₹0.84
  • 200 Day
  • ₹0.78

Resistance and Support

0.95 Pivot Speed
  • R3 1.00
  • R2 0.98
  • R1 0.97
  • S1 0.94
  • S2 0.92
  • S3 0.91

What's your outlook on Amerise Biosciences?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Amerise Biosciences has an operating revenue of Rs. 10.56 Cr. on a trailing 12-month basis. An annual revenue growth of 300% is outstanding, Pre-tax margin of 0% needs improvement, ROE of -2% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It has recently broken out of a base in its weekly chart and is trading around -1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 31 which is a POOR score indicating inconsistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 70 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Amerise Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-22 Quarterly Results
2024-08-06 Quarterly Results
2024-05-23 Audited Results
2024-01-22 Quarterly Results
2023-11-07 Quarterly Results

Amerise Biosciences F&O

Amerise Biosciences Shareholding Pattern

0%
72.07%
27.93%

About Amerise Biosciences

  • NSE Symbol
  • AMERISE
  • BSE Symbol
  • 531681
  • ISIN
  • INE673C01020

Similar Stocks to Amerise Biosciences

Amerise Biosciences FAQs

Amerise Biosciences share price is ₹0 As on 23 November, 2024 | 21:22

The Market Cap of Amerise Biosciences is ₹6.3 Cr As on 23 November, 2024 | 21:22

The P/E ratio of Amerise Biosciences is -51.4 As on 23 November, 2024 | 21:22

The PB ratio of Amerise Biosciences is 1.2 As on 23 November, 2024 | 21:22

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23